In recent years, evidence from several laboratories has indicated that various subsets of systemic lupus erythematosus exist. Some of these subsets have distinctive mucocutaneous features but more importantly they have different prevalence of renal disease—thus different prognosis. These subsets are defined by the specificity of the serum antibodies the SLE patient possesses
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with variable clinical p...
We have evaluated the autoantibody profiles in the sera of 117 patients with systemic lupus erythema...
Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease with a complex and not complete...
In recent years, evidence from several laboratories has indicated that various subsets of systemic l...
This study demonstrated that 88% of untreated systemic lupus erythematosus patients with clinical re...
At present there is considerable evidence that the pathologic processes in the nephritis of systemic...
Purpose. This study evaluates high-throughput autoantibody screening and determines associated syste...
Abstract Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease, which is autoimmu...
Fifty-seven patients suffering from systemic lupus erythematosus with different clinical features we...
We should first try to define systemic lupus erythematosus (SLE). Table 1 lists criteria proposed by...
Autoantibodies may be found years before an autoimmune disease becomes clinically apparent. For syst...
sus patients having antibodies to Ro and/or La, two major groups were distinguished by titration of ...
Journal ArticleSystemic lupus erythematosus is an autoimmune disease of unresolved cause afflicting ...
OBJECTIVE: A high number of antinuclear antibody specificities can be detected in systemic lupus ery...
Background: Anti-chromatin antibodies have recently been described in patients with systemic lupus ...
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with variable clinical p...
We have evaluated the autoantibody profiles in the sera of 117 patients with systemic lupus erythema...
Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease with a complex and not complete...
In recent years, evidence from several laboratories has indicated that various subsets of systemic l...
This study demonstrated that 88% of untreated systemic lupus erythematosus patients with clinical re...
At present there is considerable evidence that the pathologic processes in the nephritis of systemic...
Purpose. This study evaluates high-throughput autoantibody screening and determines associated syste...
Abstract Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease, which is autoimmu...
Fifty-seven patients suffering from systemic lupus erythematosus with different clinical features we...
We should first try to define systemic lupus erythematosus (SLE). Table 1 lists criteria proposed by...
Autoantibodies may be found years before an autoimmune disease becomes clinically apparent. For syst...
sus patients having antibodies to Ro and/or La, two major groups were distinguished by titration of ...
Journal ArticleSystemic lupus erythematosus is an autoimmune disease of unresolved cause afflicting ...
OBJECTIVE: A high number of antinuclear antibody specificities can be detected in systemic lupus ery...
Background: Anti-chromatin antibodies have recently been described in patients with systemic lupus ...
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease with variable clinical p...
We have evaluated the autoantibody profiles in the sera of 117 patients with systemic lupus erythema...
Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease with a complex and not complete...